Harold Edward Fleming

Insider Reports History

Location
C/O Crispr Therapeutics Ag, 610 Main Street, Cambridge, MA
Signature
Jennifer Fitzpatrick, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harold Edward Fleming:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sionna Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 20K Jun 12, 2025 Direct
Upstream Bio, Inc. Director Stock Option (Right to Buy) 17.1K Jun 10, 2025 Direct
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 13K Jun 5, 2025 Direct

Insider Reports Filed by Harold Edward Fleming

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SION Sionna Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 16, 2025 Director
UPB Upstream Bio, Inc. Jun 10, 2025 1 $0 4 Jun 12, 2025 Director
CRSP CRISPR Therapeutics AG Jun 5, 2025 1 $0 4 Jun 6, 2025 Director
SION Sionna Therapeutics, Inc. Feb 6, 2025 0 $0 3 Feb 6, 2025 Director
UPB Upstream Bio, Inc. Oct 10, 2024 1 $0 4 Oct 15, 2024 Director
UPB Upstream Bio, Inc. Oct 10, 2024 0 $0 3 Oct 10, 2024 Director
CRSP CRISPR Therapeutics AG May 30, 2024 1 $0 4 May 31, 2024 Director
CRSP CRISPR Therapeutics AG Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
CRSP CRISPR Therapeutics AG Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
CRSP CRISPR Therapeutics AG Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
CRSP CRISPR Therapeutics AG Jun 10, 2021 0 $0 3 Jun 14, 2021 Director